Claudio Chuaqui - BiogenIdec | 人才画像

基本信息

浏览量：14

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 79 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery of CC-99677, a selective targeted covalent MAPKAPK2 (MK2) inhibitor for autoimmune disorders

John Malona,Claudio Chuaqui, Boris M Seletsky,Lisa Beebe, Susan Cantin, Daniel VAN Kalken, Kelly Fahnoe,Zhigang Wang, Beth Browning, Hilary Szabo, Louise A Koopman,Tamas Oravecz,

Translational Research（2022）

引用7浏览0WOS引用

An oral and selective CDK12 inhibitor demonstrates robust anti-tumor activity

Shanhu Hu, David Moebius, Wojciech Dworakowski,Elliott Cooper, Derek LaPlaca, Sydney Alnemy,Phone Perera,Jason Marineau,Claudio Chuaqui,John P. Carulli,Eric Olson

Cancer Researchno. 12 (2022): 5393-5393

引用0浏览0引用

Combination of CDK12 inhibition and olaparib enhances genomic instability in cancer models

S. Alnemy, N. Rajagopal, P. Perera, R. Shawgo, W. Dworakowski, D. LaPlaca, J. Carulli,C. Chuaqui, S. Hu, D. Moebius

European Journal of Cancer（2022）

引用0浏览0引用

Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7

Jason J Marineau,Kristin B Hamman,Shanhu Hu,Sydney Alnemy, Janessa Mihalich,Anzhelika Kabro, Kenneth Matthew Whitmore,Dana K Winter,Stephanie Roy,Stephane Ciblat,Nan Ke,Anneli Savinainen,

JOURNAL OF MEDICINAL CHEMISTRY（2022）

引用20浏览0WOS引用

CDK11 is a selective dependency in neuroblastoma harboring loss of chromosome 1p36

M. Guenther,Y. Wei, S. Stein,A. D’Ippolito, D. Farouq, D. Moebius, J. Marineau, E. Cooper,C. Chuaqui, J. Carulli, E. Olson

European Journal of Cancer（2022）

引用0浏览0引用

Discovery of (2R)-N-[3-[2-[(3-methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a potent and selective Janus Kinase 1 (JAK1) inhibitor

Qibin Su,Erica Banks,Geraldine Bebernitz,Kirsten Bell, Cassandra F Borenstein,Huawei Chen,Claudio Chuaqui,Nanhua Deng,Andrew D Ferguson,Sameer P Kawatkar,Neil P Grimster,Linette Ruston,

JOURNAL OF MEDICINAL CHEMISTRY（2020）

引用32浏览0WOS引用

SY-5609, an orally available selective CDK7 inhibitor demonstrates broad anti-tumor activity in vivo

Shanhu Hu,Jason Marineau,Kristin Hamman,Michael Bradley,Anneli Savinainen,Sydney Alnemy,Nisha Rajagopal,David Orlando,Claudio Chuaqui,Eric Olson

Cancer Research（2019）

引用12浏览0引用

A Novel MK2 Inhibitor for the Treatment of Ankylosing Spondylitis and Other Inflammatory Diseases

Francisco Ramirez-Valle,Mary Adams,Lisa Beebe,Jian Chen,Claudio Chuaqui,Jamie Connarn, Alan Corin, Karen Dingley,J. Michael Ellis,Rajula Gaur,Lawrence Hamann,John Malona,

ARTHRITIS & RHEUMATOLOGY（2019）

引用1浏览0引用

Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors

Neil P Grimster,Erica Anderson,Marat Alimzhanov,Geraldine Bebernitz,Kirsten Bell,Claudio Chuaqui,Tracy Deegan,Andrew D Ferguson,Thomas Gero, Andreas Harsch,Dennis Huszar,Aarti Kawatkar,

JOURNAL OF MEDICINAL CHEMISTRY（2018）

引用13浏览0WOS引用

An oral and selective CDK7 inhibitor demonstrates substantial anti-tumor effect in breast and ovarian cancer models

S. Hu,J. Marineau, M. Bradley, K. Hamman, S. Alnemy,D. Smith, J. Carulli,C. Chuaqui

EUROPEAN JOURNAL OF CANCER（2018）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn